• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

循环 microRNAs 作为冠心病诊断生物标志物的临床意义。

Clinical significance of circulating microRNAs as diagnostic biomarkers for coronary artery disease.

机构信息

Institute for Translational Medicine, Qingdao University, Qingdao, China.

The Affiliated Hospital of Qingdao University, Qingdao, China.

出版信息

J Cell Mol Med. 2020 Jan;24(1):1146-1150. doi: 10.1111/jcmm.14802. Epub 2019 Nov 11.

DOI:10.1111/jcmm.14802
PMID:31709737
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6933363/
Abstract

Coronary artery disease (CAD) is one of the biggest threats to human life. Circulating microRNAs (miRNAs) have been reported to be linked to the pathogenesis of CAD, indicating the possible role in CAD diagnosis. The present study aimed to explore the expression profile of plasma miRNAs and estimate their value in diagnosis for CAD. 67 Non-CAD control subjects and 88 CAD patients were enrolled. We conducted careful evaluation by RT-PCR analysis, Spearman rank correlation coefficients analysis, Receiver Operating Characteristic (ROC) curves analysis and so on. The plasma levels of six miRNAs known to be related to CAD were measured and three of them showed obvious expression change. Circulating miR-29a-3p, miR-574-3p and miR-574-5p were all significantly increased. ROC analysis revealed the probability of the three miRNAs as biomarkers with AUCs (areas under the ROC curve) of 0.830, 0.792 and 0.789, respectively. They were significantly correlated with each other in CAD patients, suggesting the possibility of joint diagnosis. The combined AUC was 0.915, much higher than each single miRNA. Therefore, our study revealed three promising biomarkers for early diagnosis of CAD. The combination of these miRNAs may act more effectively than individual ones for CAD diagnosis.

摘要

冠状动脉疾病(CAD)是对人类生命最大的威胁之一。循环microRNAs(miRNAs)已被报道与 CAD 的发病机制有关,表明其在 CAD 诊断中可能具有一定的作用。本研究旨在探索血浆 miRNAs 的表达谱,并评估其在 CAD 诊断中的价值。纳入 67 名非 CAD 对照组和 88 名 CAD 患者。我们通过 RT-PCR 分析、Spearman 秩相关系数分析、接收者操作特征(ROC)曲线分析等进行了仔细评估。测量了已知与 CAD 相关的六种 miRNA 的血浆水平,其中三种显示出明显的表达变化。循环 miR-29a-3p、miR-574-3p 和 miR-574-5p 均显著升高。ROC 分析显示,这三个 miRNA 作为生物标志物的概率具有 0.830、0.792 和 0.789 的 AUC(ROC 曲线下的面积)。它们在 CAD 患者中彼此显著相关,表明联合诊断的可能性。联合 AUC 为 0.915,明显高于单个 miRNA。因此,我们的研究揭示了三个有希望的 CAD 早期诊断的生物标志物。这些 miRNA 的组合可能比单个 miRNA 对 CAD 诊断更有效。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8545/6933363/1841b278b632/JCMM-24-1146-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8545/6933363/530bdb97cd62/JCMM-24-1146-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8545/6933363/1841b278b632/JCMM-24-1146-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8545/6933363/530bdb97cd62/JCMM-24-1146-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8545/6933363/1841b278b632/JCMM-24-1146-g002.jpg

相似文献

1
Clinical significance of circulating microRNAs as diagnostic biomarkers for coronary artery disease.循环 microRNAs 作为冠心病诊断生物标志物的临床意义。
J Cell Mol Med. 2020 Jan;24(1):1146-1150. doi: 10.1111/jcmm.14802. Epub 2019 Nov 11.
2
Identification of plasma miR-4505, miR-4743-5p and miR-4750-3p as novel diagnostic biomarkers for coronary artery disease in patients with type 2 diabetes mellitus: a case-control study.鉴定血浆 miR-4505、miR-4743-5p 和 miR-4750-3p 作为 2 型糖尿病患者冠心病的新型诊断生物标志物:病例对照研究。
Cardiovasc Diabetol. 2024 Jul 29;23(1):278. doi: 10.1186/s12933-024-02374-0.
3
Circulating microRNAs as biomarkers for severe coronary artery disease.循环微RNA作为严重冠状动脉疾病的生物标志物
Medicine (Baltimore). 2020 Apr;99(17):e19971. doi: 10.1097/MD.0000000000019971.
4
Circulating MicroRNA-423-3p Improves the Prediction of Coronary Artery Disease in a General Population - Six-Year Follow-up Results From the China-Cardiovascular Disease Study.循环 microRNA-423-3p 可改善普通人群中冠状动脉疾病的预测-来自中国心血管疾病研究的 6 年随访结果。
Circ J. 2020 Jun 25;84(7):1155-1162. doi: 10.1253/circj.CJ-19-1181. Epub 2020 May 13.
5
Plasma Circulating Mirnas Profiling for Identification of Potential Breast Cancer Early Detection Biomarkers.血浆循环 miRNA 谱分析用于鉴定潜在的乳腺癌早期检测生物标志物。
Asian Pac J Cancer Prev. 2021 May 1;22(5):1375-1381. doi: 10.31557/APJCP.2021.22.5.1375.
6
Circulating microRNA expression profiling and bioinformatics analysis of patients with coronary artery disease by RNA sequencing.通过 RNA 测序对冠心病患者的循环 microRNA 表达谱进行分析和生物信息学分析。
J Clin Lab Anal. 2020 Jan;34(1):e23020. doi: 10.1002/jcla.23020. Epub 2019 Sep 5.
7
Identification of a 7-microRNA signature in plasma as promising biomarker for nasopharyngeal carcinoma detection.鉴定血浆中的 7 个 microRNA 特征作为鼻咽癌检测有前途的生物标志物。
Cancer Med. 2020 Feb;9(3):1230-1241. doi: 10.1002/cam4.2676. Epub 2019 Dec 19.
8
Global and targeted circulating microRNA profiling of colorectal adenoma and colorectal cancer.结直肠腺瘤和结直肠癌的全局和靶向循环 microRNA 分析。
Cancer. 2018 Feb 15;124(4):785-796. doi: 10.1002/cncr.31062. Epub 2017 Nov 7.
9
Identification of a circulating microRNAs biomarker panel for non-invasive diagnosis of coronary artery disease: case-control study.循环 microRNAs 生物标志物panel 用于非侵入性诊断冠心病的鉴定:病例对照研究。
BMC Cardiovasc Disord. 2022 Jun 24;22(1):286. doi: 10.1186/s12872-022-02711-9.
10
miR-941 as a promising biomarker for acute coronary syndrome.miR-941作为急性冠状动脉综合征的一种有前景的生物标志物。
BMC Cardiovasc Disord. 2017 Aug 22;17(1):227. doi: 10.1186/s12872-017-0653-8.

引用本文的文献

1
MiRNA-34a, miRNA-145, and miRNA-222 Expression, Matrix Metalloproteinases, TNF-α and VEGF in Patients with Different Phenotypes of Coronary Artery Disease.不同表型冠心病患者中miRNA-34a、miRNA-145和miRNA-222的表达、基质金属蛋白酶、肿瘤坏死因子-α及血管内皮生长因子
Int J Mol Sci. 2024 Dec 3;25(23):12978. doi: 10.3390/ijms252312978.
2
miR-574-5p in epigenetic regulation and Toll-like receptor signaling.miR-574-5p 在表观遗传调控和 Toll 样受体信号通路中的作用。
Cell Commun Signal. 2024 Nov 26;22(1):567. doi: 10.1186/s12964-024-01934-x.
3
MiRNA-21a, miRNA-145, and miRNA-221 Expression and Their Correlations with WNT Proteins in Patients with Obstructive and Non-Obstructive Coronary Artery Disease.

本文引用的文献

1
miR-29 contributes to normal endothelial function and can restore it in cardiometabolic disorders.miR-29 有助于维持正常的血管内皮功能,并能在代谢相关心血管疾病中恢复其功能。
EMBO Mol Med. 2018 Mar;10(3). doi: 10.15252/emmm.201708046.
2
MicroRNA-574-5p promotes cell growth of vascular smooth muscle cells in the progression of coronary artery disease.微小 RNA-574-5p 促进冠状动脉疾病进展中的血管平滑肌细胞的细胞生长。
Biomed Pharmacother. 2018 Jan;97:162-167. doi: 10.1016/j.biopha.2017.10.062. Epub 2017 Nov 6.
3
Interplay between miR-574-3p and hnRNP L regulates VEGFA mRNA translation and tumorigenesis.
miRNA-21a、miRNA-145 和 miRNA-221 的表达及其与阻塞性和非阻塞性冠状动脉疾病患者 WNT 蛋白的相关性。
Int J Mol Sci. 2023 Dec 18;24(24):17613. doi: 10.3390/ijms242417613.
4
The diagnostic value of circulating miR-532-5p in patients with asymptomatic carotid artery stenosis and its predictive significance for the occurrence of cerebral ischaemic events.循环miR-532-5p在无症状性颈动脉狭窄患者中的诊断价值及其对脑缺血事件发生的预测意义。
Arch Med Sci. 2020 Jul 3;19(5):1236-1242. doi: 10.5114/aoms.2020.96627. eCollection 2023.
5
Non-coding RNAs regulating mitochondrial function in cardiovascular diseases.非编码 RNA 调控心血管疾病中线粒体功能。
J Mol Med (Berl). 2023 May;101(5):501-526. doi: 10.1007/s00109-023-02305-8. Epub 2023 Apr 4.
6
Emerging landscape of circFNDC3B and its role in human malignancies.环状 FNDC3B 的新研究现状及其在人类恶性肿瘤中的作用
Front Oncol. 2023 Jan 31;13:1097956. doi: 10.3389/fonc.2023.1097956. eCollection 2023.
7
MicroRNAs as Biomarkers for Coronary Artery Disease Related to Type 2 Diabetes Mellitus-From Pathogenesis to Potential Clinical Application.微小 RNA 作为 2 型糖尿病相关冠状动脉疾病的生物标志物:从发病机制到潜在的临床应用。
Int J Mol Sci. 2022 Dec 29;24(1):616. doi: 10.3390/ijms24010616.
8
FADD as a key molecular player in cancer progression.FADD 作为癌症进展中的关键分子参与者。
Mol Med. 2022 Nov 8;28(1):132. doi: 10.1186/s10020-022-00560-y.
9
Underlying mechanisms of epithelial splicing regulatory proteins in cancer progression.上皮剪接调节蛋白在癌症进展中的潜在机制。
J Mol Med (Berl). 2022 Nov;100(11):1539-1556. doi: 10.1007/s00109-022-02257-5. Epub 2022 Sep 27.
10
Cardiovascular Disease-Associated MicroRNAs as Novel Biomarkers of First-Trimester Screening for Gestational Diabetes Mellitus in the Absence of Other Pregnancy-Related Complications.心血管疾病相关 microRNAs 作为无其他妊娠相关并发症的妊娠期糖尿病第一孕期筛查的新型生物标志物。
Int J Mol Sci. 2022 Sep 13;23(18):10635. doi: 10.3390/ijms231810635.
miR-574-3p与hnRNP L之间的相互作用调节VEGFA mRNA翻译及肿瘤发生。
Nucleic Acids Res. 2017 Jul 27;45(13):7950-7964. doi: 10.1093/nar/gkx440.
4
miR-574-3p acts as a tumor promoter in osteosarcoma by targeting SMAD4 signaling pathway.微小RNA-574-3p通过靶向SMAD4信号通路在骨肉瘤中发挥肿瘤促进作用。
Oncol Lett. 2016 Dec;12(6):5247-5253. doi: 10.3892/ol.2016.5355. Epub 2016 Nov 7.
5
Circulating MiR-19b-3p, MiR-134-5p and MiR-186-5p are Promising Novel Biomarkers for Early Diagnosis of Acute Myocardial Infarction.循环中的MiR-19b-3p、MiR-134-5p和MiR-186-5p是急性心肌梗死早期诊断有前景的新型生物标志物。
Cell Physiol Biochem. 2016;38(3):1015-29. doi: 10.1159/000443053. Epub 2016 Mar 4.
6
An Endocrine Genetic Signal Between Blood Cells and Vascular Smooth Muscle Cells: Role of MicroRNA-223 in Smooth Muscle Function and Atherogenesis.血细胞与血管平滑肌细胞之间的内分泌遗传信号:微小RNA-223在平滑肌功能和动脉粥样硬化发生中的作用
J Am Coll Cardiol. 2015 Jun 16;65(23):2526-37. doi: 10.1016/j.jacc.2015.03.570.
7
Circulating miR-765 and miR-149: potential noninvasive diagnostic biomarkers for geriatric coronary artery disease patients.循环miR-765和miR-149:老年冠状动脉疾病患者潜在的非侵入性诊断生物标志物。
Biomed Res Int. 2015;2015:740301. doi: 10.1155/2015/740301. Epub 2015 Jan 15.
8
Loss of MCL-1 leads to impaired autophagy and rapid development of heart failure.MCL-1 的缺失导致自噬受损和心力衰竭的快速发展。
Genes Dev. 2013 Jun 15;27(12):1365-77. doi: 10.1101/gad.215871.113.
9
Deletion of MCL-1 causes lethal cardiac failure and mitochondrial dysfunction.MCL-1 的缺失会导致致命性的心脏衰竭和线粒体功能障碍。
Genes Dev. 2013 Jun 15;27(12):1351-64. doi: 10.1101/gad.215855.113.
10
MicroRNAs and cardiac sarcoplasmic reticulum calcium ATPase-2 in human myocardial infarction: expression and bioinformatic analysis.微小 RNA 与人心肌梗死肌浆网钙离子 ATP 酶 2:表达与生物信息学分析。
BMC Genomics. 2012 Oct 15;13:552. doi: 10.1186/1471-2164-13-552.